Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib

Hind Salama; Mohammed Fahed Alzayed; Khalid Ghazi Alharbi; Zohra Khattak; Mohamed H. Omer; Leena Tahir; Ayman ALhejazi

doi:10.12659/AJCR.935090

Journal article

Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib

Hind Salama, Mohammed Fahed Alzayed, Khalid Ghazi Alharbi, Zohra Khattak, Mohamed H. Omer, Leena Tahir and Ayman ALhejazi

The American journal of case reports, Vol.23(1), pp.1-6

16/02/2022

DOI: https://doi.org/10.12659/AJCR.935090

PMID: 35171900

Abstract

Dabrafenib

Erdheim-Chester Disease

Histiocytosis, Langerhans-Cell

Patient: Female, 30-year-old Final Diagnosis: Erdheim-Chester disease Symptoms: Abdominal pain • fatigue Medication: — Clinical Procedure: — Specialty: Hematology

Metrics

1 Record Views

See more details

Details

Title: Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib
Creators - without role: Hind Salama - King Abdulaziz Medical City
Mohammed Fahed Alzayed - King Abdulaziz Medical City
Khalid Ghazi Alharbi - Cardiff University
Zohra Khattak - King Abdulaziz Medical City
Mohamed H. Omer - Cardiff University
Leena Tahir - King Saud bin Abdulaziz University for Health Sciences
Ayman ALhejazi - King Abdulaziz Medical City
Publication Details: The American journal of case reports, Vol.23(1), pp.1-6
Publisher: International Scientific Literature, Inc
Identifiers: 9921284608331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article